TM
MGNX icon

Tiger Management’s MacroGenics MGNX Stock Holding History

Tiger Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-127,967
Closed -$2.43M – 104
2017
Q4 		$2.43M Sell
127,967
-111,700
-47% -$2.09M 0.38% 33
2017
Q3 		$4.43M Hold
239,667
– – 0.8% 24
2017
Q2 		$4.2M Hold
239,667
– – 0.83% 25
2017
Q1 		$4.46M Hold
239,667
– – 0.84% 31
2016
Q4 		$4.9M Sell
239,667
-26,400
-10% -$664K 0.89% 23
2016
Q3 		$7.96M Sell
266,067
-47,073
-15% -$1.4M 1.88% 15
2016
Q2 		$8.45M Sell
313,140
-261,989
-46% -$5.91M 2.73% 14
2016
Q1 		$10.8M Hold
575,129
– – 2.7% 17
2015
Q4 		$17.8M Buy
575,129
+171,854
+43% +$5.22M 2.3% 20
2015
Q3 		$8.64M Buy
403,275
+70,000
+21% +$2.2M 1.15% 23
2015
Q2 		$12.7M Buy
333,275
+147,500
+79% +$4.85M 1.79% 19
2015
Q1 		$5.83M Hold
185,775
– – 0.98% 22
2014
Q4 		$6.51M Buy
+185,775
New +$4.63M 1.28% 17

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Tiger Management's MGNX Position: Q1 2018 in Review

Tiger Management sold out of MacroGenics (MGNX) in Q1 2018, closing a stake of 127,967 shares — an estimated $2.43M sold.

Tiger Management first reported a position in MGNX in Q4 2014 and held it in 13 quarters. The position peaked at $17.8M in Q4 2015. 132 funds tracked by Wall St. Rank hold MGNX as of Q1 2018.

  • Tiger Management reported no remaining MacroGenics position as of Q1 2018 after selling out during the quarter.
  • Tiger Management sold 127,967 MacroGenics shares in Q1 2018, an estimated $2.43M.
  • Tiger Management first reported a position in MacroGenics in Q4 2014 and held it in 13 quarters.
  • Tiger Management's MacroGenics position peaked at $17.8M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q1 2018.

Based on Tiger Management's 13F filing for Q1 2018, filed 15 May 2018.